Filing Details
- Accession Number:
- 0001570523-18-000014
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2018-03-30 15:12:49
- Reporting Period:
- 2017-12-31
- Accepted Time:
- 2018-03-30 15:12:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1559356 | Immune Therapeutics Inc. | IMUN | Pharmaceutical Preparations (2834) | 593226705 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1570523 | Jackman Robert Dailey | 401 First Street Los Altos CA 94022 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-03-24 | 1,250 | $0.15 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-03-24 | 750 | $0.16 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-03-24 | 1,000 | $0.16 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-03-24 | 1,000 | $0.16 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-03-28 | 5,000 | $0.14 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-03-29 | 5,000 | $0.14 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-03-30 | 5,000 | $0.16 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-03-31 | 1,000 | $0.17 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-06 | 1,250 | $0.15 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-06 | 5,000 | $0.15 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-06 | 3,750 | $0.15 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-06 | 900 | $0.15 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-06 | 5,100 | $0.15 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-06 | 200 | $0.15 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-08 | 3,000 | $0.15 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-14 | 500 | $0.17 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-15 | 3,500 | $0.16 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-18 | 1,680 | $0.18 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-18 | 500 | $0.19 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-18 | 3,420 | $0.19 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-18 | 5,000 | $0.18 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-18 | 100 | $0.18 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-18 | 500 | $0.19 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-18 | 300 | $0.19 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-18 | 500 | $0.19 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-18 | 1,000 | $0.19 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-21 | 200 | $0.17 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-26 | 200 | $0.17 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-27 | 2,000 | $0.17 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-05-04 | 1,000 | $0.15 | 20,800,359 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Billionaire Hedge Funds
